- Home
- RENX vs BDRX Comparison
RENX vs BDRX Comparison
Compare RENX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RENX | BDRX |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RENX | BDRX |
|---|---|---|
| Price | $0.22 | $1.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 517.1K |
| Earning Date | 03-31-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,970,752.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2770.15 | N/A |
| 52 Week Low | $0.11 | $1.22 |
| 52 Week High | $2.36 | $92.00 |
Technical Indicators
Market Signals| Indicator | RENX | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 28.35 |
| Support Level | $0.13 | $1.22 |
| Resistance Level | $0.16 | $1.38 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 45.85 | 0.93 |
Price Performance
Historical ComparisonAbout RENX RenX Enterprises Corp. Common Stock
RenX Enterprises Corp is a real estate development and environmental solutions company. It is focused on the direct acquisition and indirect investment in properties across the United States that are intended for development into green single-family or multifamily housing projects. The company also focuses on the monetization of its real estate assets. It processes source-separated green waste and is expanding into the production of sustainable, high-margin potting media and soil substrates through advanced milling technology.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.